Piper Sandler Maintains Neutral on Principal Finl Gr, Raises Price Target to $80
Piper Sandler analyst John Barnidge maintains Principal Finl Gr (NASDAQ:PFG) with a Neutral and raises the price target from $75 to $80.
JP Morgan Downgrades Principal Finl Gr to Underweight, Announces $72 Price Target
JP Morgan analyst Jimmy Bhullar downgrades Principal Finl Gr (NASDAQ:PFG) from Neutral to Underweight and announces $72 price target.
Analyst Ratings for Principal Finl Gr
Principal Finl Gr (NASDAQ:PFG) has observed the following analyst ratings within the last quarter:
Jefferies Maintains Underperform on Principal Finl Gr, Raises Price Target to $60
Jefferies analyst Suneet Kamath maintains Principal Finl Gr (NASDAQ:PFG) with a Underperform and raises the price target from $56 to $60.
Credit Suisse Downgrades Principal Finl Gr to Neutral, Raises Price Target to $86
Credit Suisse analyst Andrew Kligerman downgrades Principal Finl Gr (NASDAQ:PFG) from Outperform to Neutral and raises the price target from $82 to $86.
Morgan Stanley Maintains Equal-Weight on Principal Finl Gr, Raises Price Target to $70
Morgan Stanley analyst Nigel Dally maintains Principal Finl Gr (NASDAQ:PFG) with a Equal-Weight and raises the price target from $68 to $70.
RBC Capital Maintains Sector Perform on Principal Finl Gr, Raises Price Target to $75
RBC Capital analyst Mark Dwelle maintains Principal Finl Gr (NASDAQ:PFG) with a Sector Perform and raises the price target from $70 to $75.
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers
AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.